Imbed Biosciences

Middleton, WI · Founded 2010 · Privately Held (backing)

Developer of an advanced wound care device designed to protect wounds and support the healing process across acute and chronic conditions. Imbed Biosciences is based in Middleton, WI and was founded in 2010. Its last reported valuation was $15.7 million in Oct 2019. It has raised $40 million across 8 recorded rounds; the latest was a $3.5 million seed round in Dec 2023.

Last reported valuation
$15.7M
Oct 2026
Priced at
—
Total raised
$40.0M
Last round
Seed Round
Dec 2023
What is Imbed Biosciences worth?
$15.7Mlast reported valuation · Oct 2026

Imbed Biosciences's last reported valuation, Oct 2019. Nothing priced has surfaced since.

Free account
More of Imbed Biosciences with a free account
  • ·The complete investor list: 15 names
  • ·Watch Imbed Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Imbed Biosciences funding history

8 rounds
DateRoundRaisedPost-money
Dec 2023Seed Round$3.5M▮
May 2023Seed Round$2.5M▮
Nov 2021Early Stage VC$7.9M▮
Jun 2020Seed Round$1.5M▮
Oct 2018Seed Round$4.0M▮
Dec 2017Seed Round$1.6M▮
+ 2 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Imbed Biosciences valuation

Imbed Biosciences's last reported valuation was $15.7 million in Oct 2019. No priced round, secondary trade or fund mark has surfaced since.

How much has Imbed Biosciences raised?

Imbed Biosciences has raised $40 million across 8 recorded rounds since 2014. The largest was a $7.9 million early-stage round in Nov 2021; the most recent was a $3.5 million seed round in Dec 2023.

Imbed Biosciences has filed 10 Form Ds with the SEC since 2014, most recently in Dec 2023 ($3.5 million sold to 1 investor).

How Imbed Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Imbed Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Imbed Biosciences

What is Imbed Biosciences worth?
Imbed Biosciences is valued at $15.7M as of Oct 2026. Imbed Biosciences's last reported valuation, Oct 2019. Nothing priced has surfaced since.
How much has Imbed Biosciences raised?
Imbed Biosciences has raised $40.0M in total funding across 8 recorded rounds.
When did Imbed Biosciences last raise?
Imbed Biosciences last raised in Dec 2023 (Seed Round), raising $3.5M.